INS and diabetes mellitus: Despite the availability of new drugs, advanced educational programs, and technical solutions that permit continuous glucose monitoring and subcutaneous insulin infusion (insulin pumps), episodes of hypo- and hyperglycemia are still common and the risk of micro- and macrovascular diseases related to diabetes (eg, cardiovascular diseases, retinopathy, and nephropathy) is high.